Aphria, one of Canada’s largest medical cannabis companies, aims to obtain an essential European quality standard certification before closing its deal to buy a large distributor of pharmaceutical products in Germany. Aphria announced last week its intention to buy Densborn, Germany-based CC Pharma for 24.5 million euros ($28 million) in cash on closing and another […]
Aphria seeks EU GMP certification prior to closing deal for German distributor is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs
Read More: Aphria seeks EU GMP certification prior to closing deal for German distributor
Comments are closed, but trackbacks and pingbacks are open.